An Abu Dhabi resident has spoken about her decades-long battle with a rare autoimmune disease, and how doctors at Cleveland Clinic treated the condition.
Dania Malki, 52, suffered for 30 years from eosinophilic granulomatosis with polyangiitis (EGPA), a condition that affects two to five in every one million people each year.
Ms Malki said she visited many doctors in the UAE and US, but all of them put her on steroids to treat the symptoms that are similar to asthma.
EGPA happens when certain types of cells in a person's blood or tissues swell.
I was barely catching my breath after light activities like going up the stairs or doing groceries. There were years where I just couldn’t do anything
Dania Malki
While EGPA can affect a patient's nerves, heart and kidneys, it most commonly affects the lungs and upper airways.
Although the cause of the inflammation is unknown, experts suspect it is linked to the immune system failing to function.
It causes shortness of breath, coughing, and could easily be mistaken for asthma.
Ms Malki, a Syrian-American citizen, started to develop symptoms in 1992 while studying at a university in Los Angeles.
“It started as asthma and I was treated for it,” she said.
At the time the disease was not as well-known among doctors as it is today, she said.
Her condition flared up every few years owing to emotional stress, which aggravated the symptoms.
“It was quite erratic in my case," said Ms Malki, a communications professional and artist.
“The first bad attack happened in the late 90s, when I went back to Syria after finishing my studies in the US.
“The second time it escalated was after my divorce, nearly 10 years later, and the third time was in 2011 or so when my family was stuck in Syria during the beginning of the war.”
Dr Fulvio Salvo, an immunologist at Cleveland Clinic Abu Dhabi who treated Ms Malki, said asthma and EGPA can have a "relevant impact on the mental health of patients".
"Stress and anxiety may worsen asthma, increasing the rate of exacerbation and the use of medication," he said.
In Ms Malki’s case, there were years when she did not experience any symptoms but her condition deteriorated over time.
Every time her symptoms flared, she struggled to breathe and could not walk even for a few steps.
“I found it difficult to breathe after light activities like going up the stairs, doing groceries, or painting with oil as the solvent tends to have strong fumes,” she said.
“I love to paint and there were times when the smell of the paint would affect me so much I couldn’t do it any more.
We decided to try a new treatment, a medication that’s available here and has been shown to be effective in treating the disease
Dr Fulvio Salvo
“There were years where I just couldn’t do anything. I used to work full time and felt very weak by the end of the day.
“Eight years ago, I had to give up work because I had become too weak. I would have to lie down to rest every two hours.”
Ms Malki’s social life also suffered.
“I felt too weak to see people,” she said.
After she had the disease diagnosed, Ms Malki tried many treatments, including asthma inhalers and immunosuppressants usually given to patients who have had an organ transplant.
She was also constantly on cortisone, a steroid.
“I was going from one doctor to another. Some would know about EGPA, but most would just try to treat my asthma. I wasn’t really treated, but just put on long-term cortisone,” she said.
“Sometimes the doctors would try to stop the cortisone, telling me it’s not good to be on it for a long time, but the symptoms would come straight back when I stopped taking it.
“At the beginning, cortisone was like a magic pill as it minimised the symptoms but eventually it became almost toxic.”
In 2019, Ms Malki went to Cleveland Clinic for treatment.
“Their team of doctors introduced me to an injection, Nucala, which contains mepolizumab, a type of drug. It helps reduce asthma symptoms, specifically the ones related to eosinophilic,” she said.
The Nucala injection was first approved in the US in 2015, as an add-on maintenance treatment for patients with severe eosinophilic.
Nucala has also been found to be effective in treating EGPA, researchers in the US have said.
A recent year-long clinical study of people with the disease found out that 40 per cent of those treated with Nucala were free from symptoms for up to 36 weeks.
“When Dania came she had been struggling for a very long time," Dr Salvo said.
"She was highly symptomatic, struggled with her breathing and had many limitations in her daily life due to shortness of breath and coughing."
She had received a lot of care over the years, but was never able to achieve proper control of her symptoms, he said.
“Her symptoms were ruling her life despite the fact that she was on the maximal dose of asthma control medications, immunosuppressants and cortisone – the long-term effect of which can be very serious," he said.
Dr Salvo said he was concerned because she was on cortisone for more than 20 years.
“We decided to try a new treatment, a biologic medication that’s available here and has been shown to be effective in treating EGPA," he said.
After taking the monthly prescribed injections of Nucala, her dependence on other medications reduced gradually.
“As her condition improved, she could stop taking immunosuppressants and some of her asthma medications. Now she only receives a minimal dose of cortisone,” Dr Salvo said.
“Her condition has improved so much that she is exercising, planning to travel and hoping to display her art – paintings of street scenes and landscapes of Syria, her ancestral home.”
Ms Malki said she felt "better than ever". She is exercising again, meets friends and is making plans for the future.
“I’m on a monthly injection, but that is much better than taking several medicines with many side effects,” she said.
“Now I feel the effects of it and the results are clear.”
Doctors perform complex surgeries at Cleveland Clinic Abu Dhabi - in pictures
THE BIO:
Sabri Razouk, 74
Athlete and fitness trainer
Married, father of six
Favourite exercise: Bench press
Must-eat weekly meal: Steak with beans, carrots, broccoli, crust and corn
Power drink: A glass of yoghurt
Role model: Any good man
F1 The Movie
Starring: Brad Pitt, Damson Idris, Kerry Condon, Javier Bardem
Director: Joseph Kosinski
Rating: 4/5
Ten tax points to be aware of in 2026
1. Domestic VAT refund amendments: request your refund within five years
If a business does not apply for the refund on time, they lose their credit.
2. E-invoicing in the UAE
Businesses should continue preparing for the implementation of e-invoicing in the UAE, with 2026 a preparation and transition period ahead of phased mandatory adoption.
3. More tax audits
Tax authorities are increasingly using data already available across multiple filings to identify audit risks.
4. More beneficial VAT and excise tax penalty regime
Tax disputes are expected to become more frequent and more structured, with clearer administrative objection and appeal processes. The UAE has adopted a new penalty regime for VAT and excise disputes, which now mirrors the penalty regime for corporate tax.
5. Greater emphasis on statutory audit
There is a greater need for the accuracy of financial statements. The International Financial Reporting Standards standards need to be strictly adhered to and, as a result, the quality of the audits will need to increase.
6. Further transfer pricing enforcement
Transfer pricing enforcement, which refers to the practice of establishing prices for internal transactions between related entities, is expected to broaden in scope. The UAE will shortly open the possibility to negotiate advance pricing agreements, or essentially rulings for transfer pricing purposes.
7. Limited time periods for audits
Recent amendments also introduce a default five-year limitation period for tax audits and assessments, subject to specific statutory exceptions. While the standard audit and assessment period is five years, this may be extended to up to 15 years in cases involving fraud or tax evasion.
8. Pillar 2 implementation
Many multinational groups will begin to feel the practical effect of the Domestic Minimum Top-Up Tax (DMTT), the UAE's implementation of the OECD’s global minimum tax under Pillar 2. While the rules apply for financial years starting on or after January 1, 2025, it is 2026 that marks the transition to an operational phase.
9. Reduced compliance obligations for imported goods and services
Businesses that apply the reverse-charge mechanism for VAT purposes in the UAE may benefit from reduced compliance obligations.
10. Substance and CbC reporting focus
Tax authorities are expected to continue strengthening the enforcement of economic substance and Country-by-Country (CbC) reporting frameworks. In the UAE, these regimes are increasingly being used as risk-assessment tools, providing tax authorities with a comprehensive view of multinational groups’ global footprints and enabling them to assess whether profits are aligned with real economic activity.
Contributed by Thomas Vanhee and Hend Rashwan, Aurifer
The alternatives
• Founded in 2014, Telr is a payment aggregator and gateway with an office in Silicon Oasis. It’s e-commerce entry plan costs Dh349 monthly (plus VAT). QR codes direct customers to an online payment page and merchants can generate payments through messaging apps.
• Business Bay’s Pallapay claims 40,000-plus active merchants who can invoice customers and receive payment by card. Fees range from 1.99 per cent plus Dh1 per transaction depending on payment method and location, such as online or via UAE mobile.
• Tap started in May 2013 in Kuwait, allowing Middle East businesses to bill, accept, receive and make payments online “easier, faster and smoother” via goSell and goCollect. It supports more than 10,000 merchants. Monthly fees range from US$65-100, plus card charges of 2.75-3.75 per cent and Dh1.2 per sale.
• 2checkout’s “all-in-one payment gateway and merchant account” accepts payments in 200-plus markets for 2.4-3.9 per cent, plus a Dh1.2-Dh1.8 currency conversion charge. The US provider processes online shop and mobile transactions and has 17,000-plus active digital commerce users.
• PayPal is probably the best-known online goods payment method - usually used for eBay purchases - but can be used to receive funds, providing everyone’s signed up. Costs from 2.9 per cent plus Dh1.2 per transaction.
Our Time Has Come
Alyssa Ayres, Oxford University Press
Company profile
Company: Rent Your Wardrobe
Date started: May 2021
Founder: Mamta Arora
Based: Dubai
Sector: Clothes rental subscription
Stage: Bootstrapped, self-funded
Who was Alfred Nobel?
The Nobel Prize was created by wealthy Swedish chemist and entrepreneur Alfred Nobel.
- In his will he dictated that the bulk of his estate should be used to fund "prizes to those who, during the preceding year, have conferred the greatest benefit to humankind".
- Nobel is best known as the inventor of dynamite, but also wrote poetry and drama and could speak Russian, French, English and German by the age of 17. The five original prize categories reflect the interests closest to his heart.
- Nobel died in 1896 but it took until 1901, following a legal battle over his will, before the first prizes were awarded.
COMPANY PROFILE
Name: Xpanceo
Started: 2018
Founders: Roman Axelrod, Valentyn Volkov
Based: Dubai, UAE
Industry: Smart contact lenses, augmented/virtual reality
Funding: $40 million
Investor: Opportunity Venture (Asia)